Talis Biomedical Corporation announces expansion of Scientific Advisory Board
Published: Oct 11, 2018
Dr. Jane Schwebke, MD, joins the Talis SAB
MENLO PARK, Calif., Oct. 11, 2018 /PRNewswire/ -- Talis Biomedical Corporation is pleased to announce the expansion of their Scientific Advisory Board and the appointment of Dr. Jane Schwebke, MD, Professor of Medicine in the Infectious Disease Division at the University of Alabama at Birmingham and Consultant to the Jefferson County Department of Health STD clinic.
Talis is driven by the mission to transform medical care by enabling rapid molecular testing in the near patient setting.
Dr. Schwebke will work closely with the Talis team and with Dr. Rustem Ismagilov, chair of the SAB, to advance the mission in the areas of sexually transmitted infections and Women's Health.
Brian Coe, Talis' Chief Executive Officer, stated: "We are honored to announce the expansion of our Scientific Advisory Board. It is a testament of the scientific and clinical enthusiasm for our pioneering solution, and we are privileged to welcome Dr. Jane Schwebke to our SAB."
Dr. Schwebke stated, "I am very excited to serve on the Talis SAB. There is a critical need for rapid STD and women's health diagnostic testing and I believe Talis will provide the solution."
About Dr. Schwebke:
View original content to download multimedia:http://www.prnewswire.com/news-releases/talis-biomedical-corporation-announces-expansion-of-scientific-advisory-board-300729601.html